Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase
inhibitor of the meta-disulfamoylbenzene class.
Physician reviewed dichlorphenamide patient information - includes
dichlorphenamide description, dosage and directions.
Medscape - Periodic paralysis indication dosing for Keveyis (dichlorphenamide),
frequency-based adverse effects, comprehensive interactions, ...
Dichlorphenamide is only found in individuals that have used or taken this drug. It
is a carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
Aug 24, 2015 ... Dichlorphenamide USP is a white or practically white, crystalline compound with
a molecular weight of 305.16. It is very slightly soluble in water ...
Dichlorphenamide is used to treat inherited muscle disorders, such as primary
hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and ...
KEVEYISTM (dichlorphenamide) tablets, for oral use. Initial U.S. Approval: 1958
... concomitant use of dichlorphenamide and high-dose aspirin. The concomitant.
Jun 13, 2005 ... Pharmacodynamics, Dichlorphenamide is an oral carbonic anhydrase inhibitor
indicated for adjunctive treatment of: chronic simple ...
Apr 11, 2016 ... Dichlorphenamide (Keveyis – Taro), an oral carbonic anhydrase inhibitor, has
been approved by the FDA for treatment of primary hypokalemic ...